Status:
UNKNOWN
Effects of the Use of Adjuvant Drugs After Extracorporeal Shockwave Lithotripsy (ESWL) in Renal Calculus
Lead Sponsor:
University of Sao Paulo General Hospital
Collaborating Sponsors:
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Conditions:
Renal Calculi
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The investigators objective is to study if some drugs can improve the success rate of extracorporeal shockwave lithotripsy for renal stones.
Detailed Description
Extracorporeal shockwave lithotripsy is one of the modalities of treatment of renal stones. It´s a machine that breaks the renal stones extracorporeally. Some drugs, like alpha blockers and calcium ch...
Eligibility Criteria
Inclusion
- radiopaque renal stone, 5 to 20 mm, located at renal pelvis or superior or middle calix
Exclusion
- inferior calix, any contraindication for extracorporeal shockwave lithotripsy, pregnancy, coagulopathy, previous renal surgery, age under 18, abdominal aorta aneurism and urinary infection.
Key Trial Info
Start Date :
August 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
136 Patients enrolled
Trial Details
Trial ID
NCT01215708
Start Date
August 1 2006
End Date
December 1 2010
Last Update
October 6 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinics Hospital of University of Sao Paulo
São Paulo, São Paulo, Brazil, 05403900